← Back to all recalls
DRUG RECALLMODERATE
Fresenius Kabi: Multiple Rx Only Products
Fresenius Kabi recalls multiple injectable drugs due to hair found in product.
What to do
Do not use the affected products. Contact Fresenius Kabi for instructions on return and replacement.
Why it was recalled
Fresenius Kabi is recalling Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), along with Lidocaine HCl Injection, Naropin, and Xylocaine products, due to the presence of particulate matter (hair) found in the product.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
| Product | Strength |
|---|---|
| Lidocaine HCl Injection, USP, 2% | 100 mg |
| Xylocaine (lidocaine HCl Injection, USP), 1% | 500 mg |
| Naropin (ropivacaine hydrochloride Injection, USP), 0.5% | 100 mg |
| Xylocaine (lidocaine HCl Injection, USP), 1% | 200 mg |
| Glycopyrrolate Injection, USP | 1 mg |
Official source
Other recent recalls from Fresenius Kabi USA, LLC
Editorial summary by Recall Canary · last updated 2026-07-24 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification